HIIFS
ONCE

Harel Insurance Investments & Financial Services’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,235
Closed -$122K – 549
2018
Q3 		$122K Buy
+2,235
New +$153K 0.01% 254

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ONCE Position: Q4 2018 in Review

Harel Insurance Investments & Financial Services sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 2,235 shares — an estimated $122K sold.

Harel Insurance Investments & Financial Services first reported a position in ONCE in Q3 2018 and held it in 1 quarter. The position peaked at $122K in Q3 2018. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

  • Harel Insurance Investments & Financial Services reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 2,235 Spark Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $122K.
  • Harel Insurance Investments & Financial Services first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Spark Therapeutics, Inc. Common Stock position peaked at $122K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2018, filed 29 Jan 2019.